regenerative medicine

Allergan picks up regenerative med company for $2.9B
Allergan picks up regenerative med company for $2.9B
BioPharma Dive
Allergan
M&A
regenerative medicine
Acelity
devices
Flag link:
Bayer, Versant close $225m Series A to launch stem cell company
Bayer, Versant close $225m Series A to launch stem cell company
Mass Device
Bayer
Versant Ventures
stem cells
Series A
BlueRock Therapeutics
devices
regenerative medicine
Flag link:
Acelity spikes $1B IPO
Acelity spikes $1B IPO
Mass Device
Acelity
IPOs
wound care
regenerative medicine
devices
Flag link:
How Novartis' CEO wants to tackle an ever-aging world
How Novartis' CEO wants to tackle an ever-aging world
BioPharma Dive
Novartis
Joe Jimenez
aging
regenerative medicine
Flag link:
Avalon leads $17M round for regenerative med biotech Ankasa
Avalon leads $17M round for regenerative med biotech Ankasa
Fierce Biotech
Avalon Ventures
regenerative medicine
Ankasa
Flag link:
Celgene buys into Mesoblast's stem cell pipeline in regenerative med pact
Celgene buys into Mesoblast's stem cell pipeline in regenerative med pact
Fierce Biotech
Celgene
Mesoblast
regenerative medicine
stem cells
Flag link:
Athersys, Inc. And The Future Of Regenerative Medicine
Athersys, Inc. And The Future Of Regenerative Medicine
Seeking Alpha
Athersys
regenerative medicine
Flag link:
3 Companies Banking on Regenerative Medicine
3 Companies Banking on Regenerative Medicine
Wall St Cheat Sheet
regenerative medicine
Cellular Dynamics
Cytori
Athersys
Flag link:
Celgene Expanding R&D Portfolio Into Regenerative Medicine
Celgene Expanding R&D Portfolio Into Regenerative Medicine
Seeking Alpha
R&D
regenerative medicine
Celgene
Tengion
Flag link:
Regenerative Medicine's Time Has Come
Regenerative Medicine's Time Has Come
Seeking Alpha
regenerative medicine
NeoStem
Neuralstem
Flag link:
Deals Of The Week: Will Lightning Strike Twice At Shire
Deals Of The Week: Will Lightning Strike Twice At Shire
In Vivo Blog
Shire
Pervasis Therapeutics
regenerative medicine
Flag link:
Shire scoops up Pervasis Therapeutics
Shire scoops up Pervasis Therapeutics
Mass High Tech
Pervasis Therapeutics
Shire
M&A
regenerative medicine
Flag link:
Shire swoops to buy Advanced BioHealing
Shire swoops to buy Advanced BioHealing
Pharma Times, UK
Advanced BioHealing
Shire
M&A
diabetic foot ulcers
regenerative medicine
Flag link:
Medtronic eyes regenerative medicine market with Tengion investment
Medtronic eyes regenerative medicine market with Tengion investment
Medtronic
regenerative medicine
Tengion
artificial organs
Flag link:
Regenerative medicine gets on a profitable roll
Regenerative medicine gets on a profitable roll
Mass High Tech
regenerative medicine
Cell Therapy Group
Apligraf
Flag link:
Regenerative medicine could be $20B market in 15 years
Regenerative medicine could be $20B market in 15 years
regenerative medicine
Metronic
Flag link: